Table 3a.

Logistic regression model assessing demographic and clinical factors and PCC among the study population

	OR (95% CI), n = 882
Analyte	Univariate	Model 1	Model 2
Age, scaled to 10 years	1.31 (1.18, 1.46)	1.35 (1.20, 1.51)	1.32 (1.17, 1.50)
Sex
Male	Ref.	Ref.	Ref.
Female	2.26 (1.68, 3.06)	2.38 (1.74, 3.28)	2.70 (1.93, 3.81)
Race
White	Ref.	Ref.	Ref.
Non-white	0.84 (0.58, 1.20)	0.81 (0.54, 1.19)	0.85 (0.56, 1.28)
BMI
<30	Ref.	Ref.	Ref.
≥30	1.39 (1.04, 1.87)	1.20 (0.88, 1.65)	1.19 (0.85, 1.67)
Vaccine Status
None	Ref.	Ref.	Ref.
Partially or fully	0.83 (0.58, 1.16)	0.87 (0.60, 1.25)	0.86 (0.59, 1.26)
Diabetes
No	Ref.	Ref.	Ref.
Yes	1.69 (1.03, 2.75)	1.25 (0.72, 2.15)	1.24 (0.68, 2.21)
Plasma transfused
Control plasma	Ref.	Ref.	Ref.
CCP>5 days since symptom onset	1.05 (0.76, 1.46)	1.24 (0.87, 1.76)	1.18 (0.81, 1.72)
CCP≤5 days since symptom onset	0.72 (0.50, 1.04)	0.81 (0.54, 1.20)	0.73 (0.48, 1.11)
Log10 IL-6, pg/mL	-	-	1.59 (1.02, 2.47)